AI-Powered ECG could spot silent heart weakness before It's too late
NCT ID NCT05867407
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested an artificial intelligence tool that analyzes a standard ECG (heart electrical test) to detect when the heart's main pumping chamber is weak. Over 11,000 adults in outpatient clinics were randomly assigned to have their doctors see the AI results or not. The goal was to see if the AI helped doctors diagnose low ejection fraction (a measure of heart function) more often. The trial was stopped early, so the full impact is unknown.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Anumana Low EF AI-ECG Algorithm (device)
What this could lead to
If it works, this AI could help doctors find hidden heart weakness sooner, leading to earlier treatment and better outcomes.
What could go wrong
The trial was terminated early, so results are limited. The AI only suggests a risk; doctors still need to confirm with other tests. It may not work in all patient groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTRICULAR EJECTION FRACTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke Health
Durham, North Carolina, 27710, United States
-
Mayo Clinic Arizona
Phoenix, Arizona, 85054, United States
-
Mayo Clinic Florida
Jacksonville, Florida, 32224, United States
-
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
-
University of Texas Southwestern
Dallas, Texas, 75390, United States